Actively Recruiting
Early Newborn Screening Using Gazelle-Multispectral Testing and Comprehensive Care for Sickle Cell Disease in Infants Up to 6 Months in Cte dIvoire
Led by Swiss Tropical & Public Health Institute · Updated on 2026-10-05
120
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a new approach to improve health outcomes for children with sickle cell disease SCD aged 0 to 6 months in Cte dIvoire. The study compares a multifaceted intervention including point of care testing POCT for SCD using the Gazelle-Multispectral platform and early comprehensive care with historical data from the region. The main goals are to reduce SCD-related illnesses, lower health care visits for SCD episodes, and decrease death rates over 3.5 years of follow-up. The intervention involves newborn screening with the Gazelle-Multispectral POCT followed by confirmatory testing using HemoTypeSC. Children diagnosed with SCD will receive early treatments such as antibacterial and antimalarial prophylaxis, vaccinations for pneumococcal and Haemophilus influenzae type b, hydroxyurea therapy, and parental education on regular and urgent medical care. This comprehensive care aims to be integrated into routine health activities after the study period. Participants will be monitored over 3.5 years with regular clinical assessments to track SCD morbidity and mortality. Researchers will collect data at baseline and yearly intervals up to 3.5 years to evaluate the effectiveness and cost of the intervention compared to historical outcomes. The study includes detailed clinical records, follow-up visits, and outcome measurements to guide future SCD health policies in Cte dIvoire.
CONDITIONS
Brief Title
Integrating Point of Care Testing (POCT) For Newborn Screening and Early Care for Sickle Cell Disease in Yopougon, Côte d'Ivoire
Research Team
A
Acellam Charles Abongomera, MD, MPH, PhD
B
Benjamin Koudou, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here